Actively Recruiting
Substrates for Post-Stroke Arm Rehabilitation
Led by Massachusetts General Hospital · Updated on 2026-03-11
50
Participants Needed
1
Research Sites
238 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
N
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Difficulty moving the arm is very common and a major cause of disability after stroke. Although rehabilitation therapies (i.e., occupational and physical therapy) are the most common treatments used to improve arm motor function, it remains unknown how therapy actually changes brain pathways after stroke. This project seeks to generate fundamental knowledge about brain pathways that allow people to move their arm after stroke and how these pathways change with rehabilitation; we expect this knowledge to translate to new therapies to reduce stroke-related disability. We plan to enroll N = 50 patients with moderate to severe difficulty moving their arm after ischemic or hemorrhage stroke during the subacute period (3 to 6 months post stroke) into either 30 hours over 6 weeks of Arm Basis Training (a protocolized form of occupational therapy targeting motor control) or usual care. We will perform kinematic motor assessments, neuroimaging, and neurophysiology before and after therapy in order to test the hypothesis that intensive, target training improves arm motor control and induces corresponding anatomical and physiological changes of associated brain pathways.
CONDITIONS
Official Title
Substrates for Post-Stroke Arm Rehabilitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First time unilateral ischemic or hemorrhagic stroke occurring within 3 to 6 months
- Upper extremity motor impairment with Upper Extremity Fugl-Meyer Assessment (UE-FMA) score of 44 or less
- Ability to participate in a 6-week intensive upper extremity intervention in English as determined by a licensed occupational therapist
You will not qualify if you...
- Bilateral stroke
- Unstable medical condition affecting functional status
- Pre-stroke upper extremity injury or condition limiting use
- Visual or auditory impairment limiting ability to participate
- Significant aphasia (NIHSS sub-item 9 > 1) or cognitive deficits (NIHSS 1a, 1b, or 1c > 1)
- Known or expected inability to maintain follow-up through study and post-assessment
- Contraindications to MRI or transcranial magnetic stimulation (TMS)
- Known history of uncontrolled seizure disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Laboratory for Translational Neurorecovery, Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
C
Caroline Lambert, BA
CONTACT
J
Julie DiCarlo, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here